Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

NCT05096754 is registered in ClinicalTrials.gov with TransMedics as lead sponsor.

NCT NCT05096754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05096754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study
Lead sponsor
TransMedics
Phase
Observational
Overall status
Completed
Start date
February 3, 2020
Completion date
February 2, 2023
Enrollment
74 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant